HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The efficacy and safety of dipyrone (Novalgin) tablets in the treatment of acute migraine attacks: a double-blind, cross-over, randomized, placebo-controlled, multi-center study.

Abstract
Dipyrone, an effective analgesic drug, is widely used in the management of headache. However, few studies have evaluated its efficacy and safety in migraine. We aimed to assess the efficacy and safety of 1 g dipyrone (Novalgin, two 500 mg tablets) on pain and related symptoms in acute migraine attacks with or without aura in a double-blind, cross-over, randomized, placebo-controlled, multi-center study design. Seventy-three migraine with or without aura patients, diagnosed according to the IHS criteria, were randomized to receive dipyrone (for 2 attacks) and placebo (for 1 attack). Pain intensity was measured on a four-point verbal pain scale before and 1, 2, 4 and 24 hours after drug intake. Significant improvement of pain was achieved with dipyrone compared to placebo at all time points measured. Both patient and physician evaluations were significantly in favor of dipyrone. Side effects were few and trivial in both groups. We conclude that dipyrone is an effective, safe and cost-effective option in acute migraine management.
AuthorsF Cankat Tulunay, Hakan Ergün, Sinem Ezgi Gülmez, Taner Ozbenli, Mehmet Ozmenoğlu, Cavit Boz, Ali Kemal Erdemoglu, Adnan Varlikbas, Baki Göksan, Levent Inan
JournalFunctional neurology (Funct Neurol) 2004 Jul-Sep Vol. 19 Issue 3 Pg. 197-202 ISSN: 0393-5264 [Print] Italy
PMID15595715 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Analgesics
  • Anti-Inflammatory Agents, Non-Steroidal
  • Dipyrone
Topics
  • Adolescent
  • Adult
  • Aged
  • Analgesics (therapeutic use)
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Chi-Square Distribution
  • Cross-Over Studies
  • Dipyrone (therapeutic use)
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Migraine with Aura (complications, drug therapy)
  • Migraine without Aura (complications, drug therapy)
  • Pain Measurement
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: